title: [Atypical neuroleptics in the treatment of atypical facial neuralgia. Two case reports].
abstract: The criteria for the diagnosis of the atypical facial neuralgia make it is possible to classify under this neurological diagnosis also psychiatric disorders as conasthetic depression. In two case reports it is told about patients with both diagnosis. Due to this they were treated with an atypical neurolepticum (Olanzapine) to reach three targets: Therapy of the depression, pain i.e. atypical facial neuralgia and mood stabilizing. Within the last four years there were no side-effects as EPMS to observe.
authors.affiliation: Schmerzambulanz der Klinik für Anästhesiologie und Intensivtherapie, Universität Magdeburg, Germany. Michael.Brinkers@med.ovgu.de
authors.forename: Michael
authors.initials: M
authors.lastname: Brinkers
authors.forename: Tobias
authors.initials: T
authors.lastname: Petz
authors.forename: Anett
authors.initials: A
authors.lastname: Voigt
authors.forename: Bernd
authors.initials: B
authors.lastname: Steinig
authors.forename: Dieter
authors.initials: D
authors.lastname: Hoffmeyer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines / Q000008:administration & dosage; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D005156:Facial Neuralgia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D016896:Treatment Outcome